SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer. - Gutiérrez-Chamorro, Lucía; Felip, Eudald; Castellà, Eva; Quiroga, Vanessa; Ezeonwumelu, Ifeanyi Jude; Angelats, Laura; Esteve, Anna; Perez-Roca, Laia; Martínez-Cardús, Anna; Fernandez, Pedro Luis; Ferrando-Díez, Angelica; Pous, Anna; et al. (Cellular Oncology (2211-3428), 2024)